[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-postoperative-pain\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-postoperative-pain":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,40,72,103,134,156,181,203],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100643504","cardiac-surgery-the-incidence-and-impact-of-chronic-postoperative-pain-a-survey-100643504",false,"NCT07640646","Cardiac Surgery, the Incidence and Impact of Chronic postOperative Pain: a Survey","Cardiac COPS","Inclusion Criteria:\n\n1. Adults, aged ≥ 18 years of age, who underwent cardiac surgery (valvular, coronary bypass, other intracardiac or aortic surgery) during the 1 year recruitment period\n2. Able to provide informed consent\n3. Able to respond by telephone\n\nExclusion Criteria:\n\n1. Deceased\n2. Refusal\n3. Chronic pain in the surgical region","ALL","18 Years",{"count":19,"type":20},1000,"ESTIMATED","1 Year","OBSERVATIONAL","This survey study aims to investigate the incidence of Chronic post surgical pain (CPSP) in cardiac surgery patients treated at UZ Leuven. The primary hypothesis is that the incidence of CPSP at 3 months postoperatively is lower than 33%, which is the rate commonly reported in the literature. Secondary objectives include comparing CPSP incidence based on the type of surgical incision, as well as comparing incidences between type of surgery. Finally, the study will assess pain intensity, interference with daily activities, and quality of life of 3 months and when required also at 1 years postoperatively.",[25,26],"Chronic Postoperative Pain","Cardiac Surgery","RECRUITING","2026-06-05",{"date":30,"type":31},"2026-06-11","ACTUAL",{"date":33,"type":31},"2026-06-01",{"date":35,"type":20},"2028-05-31",{"name":37,"class":38},"Universitaire Ziekenhuizen KU Leuven","OTHER",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":47,"enrollmentInfo":48,"targetDuration":4,"studyType":50,"phases":51,"briefSummary":53,"conditions":54,"keywords":58,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":4},"100626345","phase-4-comparison-of-the-efficacy-and-safety-of-intravenous-buprenorphine-administered-via-pca-system-versus-oxycodone-in-the-management-of-postoperative-pain-after-video-assisted-thoracoscopic-surgery-100626345","NCT07434427","Comparison of the Efficacy and Safety of Intravenous Buprenorphine Administered Via PCA System Versus Oxycodone in the Management of Postoperative Pain After Video-Assisted Thoracoscopic Surgery","Comparison of the Efficacy and Safety of Intravenous Buprenorphine Administered Via PCA System Versus Oxycodone in the Management of Postoperative Pain After Video-Assisted Thoracoscopic Surgery - A Prospective, Randomized Clinical Trial","Inclusion Criteria:\n\n* qualification for elective thoracic surgery performed using the VATS technique, physical status ASA I-III, anticipated use of PCA in the postoperative period, patient's consent to participate in the study.\n\nExclusion Criteria:\n\n* inability to provide informed consent,\n* hypersensitivity to opioids or study medications,\n* chronic opioid therapy,\n* previously diagnosed chronic pain,\n* chronic use of analgesic medications,\n* disorders of consciousness preventing appropriate use of the PCA pump,\n* severe renal or hepatic insufficiency,\n* pregnancy or breastfeeding,\n* clinically relevant drug interactions (rifampicin, carbamazepine, CYP3A4 inhibitors).","75 Years",{"count":49,"type":20},200,"INTERVENTIONAL",[52],"PHASE4","The goal of this clinical trial is to learn whether intravenous buprenorphine administered via a patient-controlled analgesia (PCA) system provides effective and safer postoperative pain control than intravenous oxycodone PCA in adults undergoing video-assisted thoracoscopic surgery (VATS). It will also evaluate the overall tolerability of buprenorphine in the early postoperative period and explore longer-term pain outcomes. The main questions it aims to answer are:\n\nDoes buprenorphine PCA provide pain control that meets predefined targets during the first 48 hours after VATS (both at rest and during respiratory rehabilitation\u002Fmobilization), compared with oxycodone PCA? Does buprenorphine PCA reduce clinically relevant respiratory safety events (e.g., apnea or oxygen desaturation requiring intervention) and excessive sedation, compared with oxycodone PCA? What opioid-related adverse effects (e.g., nausea\u002Fvomiting, pruritus, constipation, hypotension) occur with buprenorphine PCA versus oxycodone PCA? Does buprenorphine PCA affect time to first patient-initiated analgesic demand and total opioid consumption within 48 hours? Does the choice of PCA opioid influence quality of recovery and the incidence of persistent postoperative pain at follow-up?\n\nResearchers will compare buprenorphine PCA to oxycodone PCA (both as part of standardized multimodal analgesia and perioperative care, including serratus anterior plane block) to determine whether buprenorphine provides non-inferior analgesia with a superior safety profile.\n\nParticipants will:\n\nBe randomly assigned (double-blind) to receive buprenorphine PCA or oxycodone PCA for 48 hours after surgery, alongside standard multimodal analgesia Receive standardized general anesthesia for VATS with one-lung ventilation and an ultrasound-guided serratus anterior plane block at the end of surgery Have pain scores (NRS) recorded at multiple time points over 48 hours, at rest and during rehabilitation, and complete recovery questionnaires (QoR-15) early after surgery Be monitored regularly for vital signs, sedation level (RASS), respiratory events, and other adverse effects, with total opioid use recorded Provide satisfaction ratings at discharge and be followed after discharge to assess persistent postoperative pain\u002Fhyperalgesia at 1, 3, and 6 months",[55,25,56,57],"Acute Postoperative Pain","Toracosurgery","Video-assisted Thoracis Surgery (VATS)",[59,60,61],"pain","acute postoperative pain","chronic postoperative pain","NOT_YET_RECRUITING","2026-02-20",{"date":65,"type":31},"2026-02-25",{"date":67,"type":20},"2026-02",{"date":69,"type":20},"2027-11",{"name":71,"class":38},"Medical University of Silesia",{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":80,"enrollmentInfo":81,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":83,"conditions":84,"keywords":88,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":39},"100612758","comparison-of-iv-analgesia-thoracic-epidural-analgesia-and-esp-block-for-chronic-pain-after-open-heart-surgery-100612758","NCT07257744","Comparison of IV Analgesia, Thoracic Epidural Analgesia, and ESP Block for Chronic Pain After Open Heart Surgery","A Comparative Evaluation of Intravenous Analgesia, Thoracic Epidural Analgesia, and Erector Spinae Plane Block on Chronic Postoperative Pain Following Open Heart Surgery","TEA-ESPB-IV","Inclusion Criteria:\n\n* Adults aged 18 to 85 years\n* Classified as ASA physical status I-III\n* Scheduled to undergo open heart surgery with median sternotomy\n* BMI \\\u003C 35 kg\u002Fm²\n* Able to understand and provide written informed consent\n* Eligible to receive any of the routine analgesia methods (intravenous analgesia, thoracic epidural analgesia, or erector spinae plane block)\n\nExclusion Criteria:\n\n* Age \\\u003C 18 or \\> 85 years\n* BMI ≥ 35 kg\u002Fm²\n* Coagulation disorders\n* Infection at the intervention site\n* Known allergy to local anesthetics or induction agents\n* Psychiatric disorders limiting cooperation\n* Use of chronic pain medications, antidepressants, corticosteroids, antiepileptics, or routine analgesics\n* Inability to cooperate, communicate, or follow commands\n* Physical or verbal performance impairment\n* Previous open heart surgery","85 Years",{"count":82,"type":20},90,"This prospective observational study aims to compare three routinely used postoperative analgesia techniques in patients undergoing open heart surgery: intravenous analgesia, thoracic epidural analgesia (TEA), and bilateral erector spinae plane block (ESPB). The primary objective is to evaluate the impact of these analgesia modalities on the development of chronic postoperative pain at 3 months. Secondary objectives include assessing postoperative acute pain scores, additional analgesic requirements, extubation time, mobilization time, intensive care unit stay, hospital stay, respiratory complications, and the relationship between acute and chronic pain. No intervention is assigned by protocol, and all analgesia methods are applied as part of routine clinical practice.",[25,85,86,87],"Open Heart Surgery","Postoperative Analgesia","Analgesia",[85,25,89,90,91,92,93],"Post-Sternotomy Pain","Thoracic Epidural Analgesia (TEA)","Erector Spinae Plane Block (ESPB)","Pain Management","Cardiac Anesthesia","2025-11-27",{"date":96,"type":31},"2025-12-02",{"date":98,"type":31},"2025-02-15",{"date":100,"type":20},"2026-04-20",{"name":102,"class":38},"Karadeniz Technical University",{"id":104,"slug":105,"hasResults":11,"nctId":106,"briefTitle":107,"officialTitle":108,"acronym":109,"eligibilityCriteria":110,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":111,"enrollmentInfo":112,"targetDuration":4,"studyType":50,"phases":114,"briefSummary":116,"conditions":117,"keywords":118,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":127,"completionDateStruct":129,"leadSponsor":131,"locationsCount":133},"100561044","placebo-effect-in-spinal-cord-electrical-stimulation-for-pain-100561044","NCT06585033","Placebo Effect In Spinal Cord Electrical Stimulation for Pain","Spinal Cord Stimulation for the Treatment of Therapy-Resistant Neuropathic Pain After Lumbar Spinal Surgery - A Randomized, Double-Blind, Sham-Controlled, Cross-over Study","PISCES","Inclusion Criteria:\n\n* History consistent with PSPS2 of at least 6 months after the last spinal surgery. The patient experienced no effect of conservative treatments and has been assessed as not eligible for further spinal surgery.\n* Patients between 18-70 years of age.\n* Average perceived pain intensity in one or both legs of 5 or more and average perceived pain intensity in the back of less than 3 measured with the validated 11-box NRS (0 no pain, 10 worst imaginable pain)\n* The patient should have been informed verbally and in writing about the study and should have provided informed written consent to participate.\n* Adequate pain relief effect (50% or more) after a two week trial with active test stimulation.\n\nExclusion Criteria:\n\n* Subject is unable to understand or operate the SCS device.\n* Subject currently has an active implantable device including pacemakers, spinal cord stimulator or intrathecal drug delivery system.\n* Ongoing coagulation disorder.\n* Ongoing abuse of alcohol, drugs, or prescription opioids.\n* Active debilitating psychiatric illness.\n* Active malignancy.\n* Condition with increased general infection sensitivity, such as known immunodeficiency.\n* Expected lifespan \\<1 year.\n* Ongoing local infection or other skin disease where the IPG is planned to be placed.\n* Pregnancy.","70 Years",{"count":113,"type":20},50,[115],"NA","Objective: To evaluate if spinal cord stimulation (SCS) performs better than placebo (no stimulation) in the long term to reduce persistent neuropathic leg pain refractory to medication and other conservative treatments in patients who have undergone lumbar spinal surgery.\n\nStudy design: Multicenter, double blind, randomized, sham-controlled trial.\n\nAfter a positive SCS test trial, participants (18-70 years) will be implanted with a non-rechargeable SCS system providing active, subthreshold stimulation and followed for 12 months in a blinded cross-over design. The primary outcome measure is the difference in change in leg pain intensity scores using the Numeric Rating Scale (NRS) between a 3-month period with optimized subthreshold stimulation, and a 3-month period with no stimulation, as compared to baseline. Quality of life, physical functioning, sleep quality, return to work, and reduction in medication use will also be investigated.\n\nBackground: Up to 20% of patients who have undergone lumbar spinal surgery experience persistent back\u002Fleg pain leading to long-term reduction in functionality and quality of life. SCS is an established and safe, minimally invasive treatment for these patients when no further surgery is indicated and conservative therapies have been found to be ineffective. Placebo-controlled studies, comparing active and sham stimulation, were lacking until recently as traditional SCS relied on the patient feeling the stimulation (paresthesia). Technological progress with development of paresthesia-free stimulation forms now allows for the execution of placebo-controlled studies. A recent trial showing no significant difference in long-term effectiveness between active SCS and sham suffers from significant methodological shortcomings. This necessitates further sham-controlled studies to determine the effectiveness of SCS.",[25],[119,120,121,122,123,124],"Spinal cord stimulation","Lumbar spine surgery","Chronic pain","Pain reduction","Placebo","Randomized controlled trial","2025-11-24",{"date":96,"type":31},{"date":128,"type":31},"2024-11-15",{"date":130,"type":20},"2027-06-30",{"name":132,"class":38},"Sahlgrenska University Hospital",4,{"id":135,"slug":136,"hasResults":11,"nctId":137,"briefTitle":138,"officialTitle":138,"acronym":139,"eligibilityCriteria":140,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":141,"targetDuration":4,"studyType":50,"phases":143,"briefSummary":144,"conditions":145,"keywords":4,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":146,"lastUpdatePostDateStruct":147,"startDateStruct":149,"completionDateStruct":151,"leadSponsor":153,"locationsCount":155},"100605290","benefit-on-chronic-pain-of-early-screening-and-management-of-patients-with-persistent-postoperative-pain-at-3-months-100605290","NCT07160595","Benefit on Chronic Pain of Early Screening and Management of Patients With Persistent Postoperative Pain at 3 Months","DROPS","Inclusion Criteria:\n\n* Patients who have undergone one of the following procedures:\n\n  * Inguinal hernia repair, regardless of the surgical technique used\n  * Breast reduction\n  * Mastectomy with or without reconstruction but with lymph node dissection\n  * Knee arthroscopy or knee ligamentoplasty\n\n    * Patients with a smartphone\n    * French-speaking patients\n    * Patients affiliated with a social security\n    * Patients who have given their free and informed verbal consent\n\nExclusion Criteria:\n\n* Patients with pain sensitivity defined by the presence of chronic pain, use of level 3 morphine analgesics, use of anxiolytics, gabapentinoids and\u002For antidepressants\n* Patients subject to legal protection measures\n* Patients deprived of their liberty\n* Pregnant, labouring or breastfeeding patients",{"count":142,"type":20},2052,[115],"Chronic postoperative pain has an overall incidence of approximately 30%, with 5% to 10% of cases classified as severe (numerical rating scale \\> 6\u002F10). However, its management remains suboptimal, primarily due to underdiagnosis and delayed referral of patients to specialized chronic pain centers.\n\nImproving the screening of patients with chronic postoperative pain is therefore crucial. Our research has shown that early detection of postoperative neuropathic pain is possible using just two text messages (SMS), as early as three months after surgery. Early screening, combined with prompt management, can prevent pain from becoming chronic and mitigate its harmful effects.\n\nStudy design\n\nThis study is a cluster crossover randomized trial. All participating centers (n=16) will take part in two sequential study periods:\n\n* Control Period: \"Without early treatment at 3 months\" During this period, patients with persistent postoperative pain-identified via SMS-will receive treatment at 6 months. This reflects the current standard of care for patients with postoperative pain.\n* Intervention Period: \"With early treatment at 3 months\" During this period, patients with persistent postoperative pain-identified via SMS-will receive early treatment starting at 3 months.\n\nStudy Population\n\nThe study will include patients undergoing the following minor surgical procedures:\n\n* Inguinal hernia repair\n* Breast reduction\n* Mastectomy with lymph node dissection\n* Knee arthroscopy\n* Knee ligament reconstruction\n\nStudy Schedule Recruitment Period: 24 months Patient Follow-up: 6 months Total Estimated Study Duration: 30 months",[25],"2025-09-05",{"date":148,"type":31},"2025-09-08",{"date":150,"type":20},"2025-11",{"date":152,"type":20},"2028-04",{"name":154,"class":38},"Fondation Hôpital Saint-Joseph",16,{"id":157,"slug":158,"hasResults":11,"nctId":159,"briefTitle":160,"officialTitle":160,"acronym":4,"eligibilityCriteria":161,"healthyVolunteers":11,"sex":16,"minAge":162,"maxAge":17,"enrollmentInfo":163,"targetDuration":4,"studyType":50,"phases":165,"briefSummary":166,"conditions":167,"keywords":4,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":171,"lastUpdatePostDateStruct":172,"startDateStruct":174,"completionDateStruct":176,"leadSponsor":178,"locationsCount":180},"100565150","prevention-of-postsurgical-chronic-pain-in-children-and-adolescents-prevendol-100565150","NCT06638437","Prevention of Postsurgical Chronic Pain in Children and Adolescents (PREVENDOL)","Inclusion Criteria:\n\n1. Having to undergo surgery\n2. Being between 8 and 18 years old;\n3. Having signed the informed consent\n4. Having an ASA risk between I and III\n\nExclusion Criteria:\n\n1. Not being able to understand Spanish\n2. Having a physical and\u002For cognitive impairment that interferes with understanding the instructions and handling of the application (e.g., moderate to severe intellectual disability, blindness)\n3. Participating in another clinical trial\n4. Undergoing an urgent surgical intervention\n5. Being hospitalized in intensive care due to the need for ventilation or hemodynamic support or other complications\n6. Having an ASA risk of IV\n7. Not having signed the informed consent","8 Years",{"count":164,"type":20},125,[115],"Chronic postsurgical pain is a health problem with a great societal impact: approximately 20% of all children and adolescents undergoing surgery will develop chronic pain. Importantly, the risk and protective factors that are known (e.g., anxiety, catastrophizing, pain beliefs and pain coping) are modifiable, thus there is a huge potential for the development of both preventive and protective programs to avoid the transition from acute to chronic pain or reduce the impact in the lives of patients when it has already developed.",[168,169,25,170],"Chronic Postsurgical Pain","Chronic Post-surgical Pain","Chronic Post-operative Pain","2024-10-11",{"date":173,"type":31},"2024-10-16",{"date":175,"type":20},"2025-02-01",{"date":177,"type":20},"2026-12-31",{"name":179,"class":38},"University Rovira i Virgili",3,{"id":182,"slug":183,"hasResults":11,"nctId":184,"briefTitle":185,"officialTitle":185,"acronym":4,"eligibilityCriteria":186,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":111,"enrollmentInfo":187,"targetDuration":4,"studyType":50,"phases":188,"briefSummary":189,"conditions":190,"keywords":191,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":194,"lastUpdatePostDateStruct":195,"startDateStruct":197,"completionDateStruct":199,"leadSponsor":201,"locationsCount":39},"100537715","a-comparative-effect-of-echogenic-needle-for-nerve-block-on-acute-and-chronic-postoperative-pain-100537715","NCT06281431","A Comparative Effect of Echogenic Needle for Nerve Block on Acute and Chronic Postoperative Pain","Inclusion Criteria:\n\n1. The age is above 18 years old and below 70 years old.\n2. patients whose surgical sites were in the chest, abdomen, upper limbs or lower limbs, including lobectomy, cholecystectomy, gastrointestinal resection, hysterectomy and other elective operations.\n3. This operation was the first operation during the hospitalization.\n4. Consent to participate in this study and sign an informed consent form.\n\nExclusion Criteria:\n\n1. Patients with a history of alcohol or drug addiction.\n2. Patients with disturbance of consciousness before operation.\n3. Other conditions considered by the attending physician or researcher to be inappropriate for the study;\n4. History of chronic pain.\n5. Abnormal coagulation function.",{"count":19,"type":20},[115],"Surgical pain is a common complication after surgery, affecting patient recovery and treatment quality. \\>20% of patients suffer from chronic postoperative pain. China has \\>70 million surgeries yearly. Nerve block manages postoperative pain, with developing nerve block needles now used in clinics. Developed needles may have better pain management effects than non-developed ones, but their effect on reducing chronic pain remains unclear. This study aims to explore the effect of developed nerve block needles on postoperative pain and compare them to non-developed needles, providing new ideas and methods for pain management.",[25],[192,193,121],"Visualized nerve block needle","Acute pain","2024-08-13",{"date":196,"type":31},"2024-08-14",{"date":198,"type":31},"2023-06-12",{"date":200,"type":20},"2025-09-30",{"name":202,"class":38},"The Second Affiliated Hospital of Chongqing Medical University",{"id":204,"slug":205,"hasResults":11,"nctId":206,"briefTitle":207,"officialTitle":208,"acronym":4,"eligibilityCriteria":209,"healthyVolunteers":210,"sex":211,"minAge":17,"maxAge":212,"enrollmentInfo":213,"targetDuration":4,"studyType":50,"phases":215,"briefSummary":216,"conditions":217,"keywords":218,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":220,"lastUpdatePostDateStruct":221,"startDateStruct":223,"completionDateStruct":225,"leadSponsor":226,"locationsCount":39},"100518933","preoperative-erector-spinae-plane-block-versus-paravertebral-plane-block-in-decreasing-post-mastectomy-pain-syndrome-100518933","NCT06036979","Preoperative Erector Spinae Plane Block Versus Paravertebral Plane Block in Decreasing Post Mastectomy Pain Syndrome","A Comparative Study Between Preoperative Erector Spinae Plane Block Versus Preoperative Paravertebral Plane Block in Decreasing Post Mastectomy Pain Syndrome. A Randomized Controlled Study.","Inclusion Criteria:\n\n* Age ≥ 18 years and ≤ 60 years old.\n* Female patients ASA ΙΙ, ΙΙΙ.\n* Female patients scheduled for unilateral breast surgeries.\n\nExclusion Criteria:\n\n* Patient refusal.\n* Patients have sepsis\n* Patients known to have allergy against local anesthetics.\n* Patients with prior surgery in areas above or below the clavicle or in the axillary region.\n* Patients with opioid dependence, alcohol or drug abuse.\n* Patient with coagulopathy.\n* Patients with psychiatric illness that prevent them from proper pain perception and assessment.\n* ASA 4 or higher.",true,"FEMALE","60 Years",{"count":214,"type":20},51,[115],"Breast cancer is considered the commonest malignancy affecting women with an incidence exceeding one million cases per year. Although it has a favorable prognosis with improved lines of treatment, some complications may still disturb the patient's life quality. One of these complications is post-mastectomy pain syndrome (PMPS) .Regional Anaesthesia (RA) is considered one of the most effective methods in reducing acute pain after breast surgeries, these include pectoral nerves block (PECS), serratus anterior plane block (SAPB), paravertebral plane block (PVPB) and erector spinae plane block (ESPB) . Our study is aiming for comparing the effect of preoperative PVPB versus preoperative ESPB in the prevention of PMPS in patients undergoing unilateral breast surgeries.",[25],[219],"PVPB, ESPB, prevention of PMPS","2024-06-27",{"date":222,"type":31},"2024-06-28",{"date":224,"type":20},"2024-07-01",{"date":175,"type":20},{"name":227,"class":38},"National Cancer Institute, Egypt"]